Literature DB >> 12372340

Conventional protein kinase C mediates phorbol-dibutyrate-induced cytoskeletal remodeling in a7r5 smooth muscle cells.

Chi-Ming Hai1, Penelope Hahne, Elizabeth O Harrington, Mario Gimona.   

Abstract

Phorbol dibutyrate (PDBu) induced the formation of podosome-like structures together with partial disassembly of actin stress fibers in A7r5 smooth muscle cells. These podosomes contained alpha-actinin, F-actin, and vinculin and exhibit a tubular, column-like structure arising perpendicularly from the bottom of PDBu-treated cells. The conventional protein kinase C (PKC) antagonist, GO6976, inhibited PDBu-induced cytoskeletal remodeling at 0.1 microM, whereas the novel PKC antagonist, rottlerin, was ineffective at 10 microM. PDBu induced the translocation of the conventional PKC-alpha but not the novel PKC-delta to the sites of podosome formation in A7r5 cells. Although partial disassembly of actin stress fibers was observed in both Y-27632- and PDBu-treated cells, focal adhesions were much reduced in number and size only in Y-27632-treated cells. Furthermore, PDBu restored focal adhesions in Y-27632-treated cells. Live video fluorescence microscopy of alpha-actinin GFP revealed a lag phase of about 20 min prior to the rapid formation and dynamic reorganization of podosomes during PDBu treatment. These findings suggest that conventional PKCs mediate PDBu-induced formation of dynamic podosome-like structures in A7r5 cells, and Rho-kinase is unlikely to be the underlying mechanism. The podosome columns could represent molecular scaffolds where PKC-alpha phosphorylates regulatory proteins necessary for Ca(2+) sensitization in smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372340     DOI: 10.1006/excr.2002.5592

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  48 in total

1.  Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells.

Authors:  Mario Gimona; Irina Kaverina; Guenter P Resch; Emmanuel Vignal; Gerald Burgstaller
Journal:  Mol Biol Cell       Date:  2003-03-20       Impact factor: 4.138

Review 2.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

Review 3.  Adhesions ring: a structural comparison between podosomes and the immune synapse.

Authors:  Sarah A Wernimont; Christa L Cortesio; William T N Simonson; Anna Huttenlocher
Journal:  Eur J Cell Biol       Date:  2008-03-17       Impact factor: 4.492

Review 4.  Signaling inputs to invadopodia and podosomes.

Authors:  Daisuke Hoshino; Kevin M Branch; Alissa M Weaver
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

5.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

Review 6.  Palladin regulation of the actin structures needed for cancer invasion.

Authors:  Paul Najm; Mirvat El-Sibai
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 7.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

8.  Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.

Authors:  S M Goicoechea; R García-Mata; J Staub; A Valdivia; L Sharek; C G McCulloch; R F Hwang; R Urrutia; J J Yeh; H J Kim; C A Otey
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

9.  MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.

Authors:  Manuela Quintavalle; Leonardo Elia; Gianluigi Condorelli; Sara A Courtneidge
Journal:  J Cell Biol       Date:  2010-03-29       Impact factor: 10.539

10.  Palladin contributes to invasive motility in human breast cancer cells.

Authors:  S M Goicoechea; B Bednarski; R García-Mata; H Prentice-Dunn; H J Kim; C A Otey
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.